Calidad de vida relacionada con la salud en pacientes con trasplante de progenitores hematopoyéticos

Referencias bibliográficas

• Gilleece MH. Blood and marrow transplant handbook: comprehensive guide for patient care. Bone Marrow Transplant. 2011; 46:1590. Doi:10.1038/bmt.2011.200. [ Links ]
• Schwartzmann L. Calidad de vida relacionada con la salud: aspectos conceptuales. Ciencia y Enfermería 2003;9(2): 9-21. [ Links ]
• Jaime-Pérez JC, Sandoval-Villa CC, Marfil-Rivera LJ, Rodríguez-Martínez M, Herrera-Garza JL, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Gómez-Almaguer D. Evaluación de la calidad de vida en pacientes del Noreste de México con enfermedades hematológicas. Rev Hematol Mex. 2011; 12(2):62-67. [ Links ]
• Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B, Passweg J, Miralbell R, Chalandon Y. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2008;42(12):819-27. Doi: 10.1038/bmt.2008.253. [ Links ]
• García CM, Mumby PB, Thilges S, Stiff PJ. Comparison of early quality of life outcomes in autologous and allogeneic transplant patients. Bone Marrow Transplant. 2012 Dec;47(12):1577-82. Doi: 10.1038/bmt.2012.77. [ Links ]
• Medd PG, Peniket AJ, Littlewood TJ, Pearce R. Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study. Bone Marrow Transplant. 2013 Jul;48(7):982-7. Doi: 10.1038/bmt.2012.261. [ Links ]
• Majhail NS, Douglas Rizzo J. Surviving the cure: long term follow up of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2013 Jan; 48(9):1145-1151. Doi:10.1038/bmt.2012.258. [ Links ]
• 8. Braamse AM, Gerrits MM, van Meijel B, Visser O, van Oppen P, Boenink AD, et al. Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transplant. 2011 Jul; 47(6):757-769. Doi:10.1038/bmt.2011.130. [ Links ]
• Khalafallah A, McDonnell K, Dawar H. U, Robertson I, Woods D. Quality of life assessment in multiple myeloma patients undergoing dose-reduced tandem autologous stem cell transplantation. Mediterr J Hematol Infect Dis 2011, 3(1): e2011057. Doi 10.4084/MJHID.2011.057. [ Links ]
• Tendas A, Pignatelli AC, Sollazzo F, Veggia B, Conte E, D'Apolito A, et al. Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party. Síntoma J Pain Administrar. 2013, Mar 14. PII: S0885-3924(13):00117-6. Doi: 10.1016/j.jpainsymman.2012.12.007. [ Links ]
• Herzberg PY, Lee SJ, Heussner P, Mumm FH, Hilgendorf I, von Harsdorf S, et al. Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center. Bone Marrow Transplantat. 2013 Jan; 48(1):129-34. Doi: 10.1038/bmt.2012.83. [ Links ]
• Alonso J, Regidor E, Barrio G, Prieto L, Rodríguez C, De La Fuente L. Valores poblacionales de referencia de la versión española del Cuestionario de Salud SF-36. Med Clin. 1998; 111(11):410-6. [ Links ]
• Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, et al. El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit. 2005; 19(2):135-150. [ Links ]
• Vilagut G, Valderas JM, Ferrer M, Garin O, López-García E, Alonso J. Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: Componentes Físico y Mental. Med Clin (Barc). 2008 May 24;130(19):726-35. [ Links ]